Immune Technology Corp. is a biotechnology company based in New York, specializing in the development and manufacture of viral antigens and anti-viral antibodies for the diagnosis, monitoring, and treatment of significant viral infectious diseases.
Product Portfolio:
- Primary Antibodies: A broad selection targeting various bacterial and viral antigens, tumor markers, and disease-related biomarkers.
- Bacterial and Viral Antigens: Products designed for research and diagnostic applications.
- ELISA Kits: Assay kits for detecting specific proteins or antibodies, including those related to HIV, Influenza, and Flavivirus.
Custom Services:
- Protein Production: Offers protein production services using various expression systems, including mammalian cells (HEK-293), baculovirus, yeast, and E. coli.
- Plasmid Production: Provides customized plasmid manufacturing services at scales ranging from milligrams to grams, utilizing proprietary processes validated through cGMP manufacturing.
